• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

继发于原发性胃弥漫性大B细胞淋巴瘤的胃腺癌

Gastric Adenocarcinoma Secondary to Primary Gastric Diffuse Large B-cell Lymphoma.

作者信息

Sakr Riwa, Massoud Marcel, Aftimos Georges, Chahine Georges

机构信息

Department of Hematology-Oncology, Centre Hospitalier Universitaire Notre Dame des Secours, Byblos, Lebanon.

Department of Hematology-Oncology, Faculty of Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.

出版信息

J Gastric Cancer. 2017 Jun;17(2):180-185. doi: 10.5230/jgc.2017.17.e11. Epub 2017 Mar 22.

DOI:10.5230/jgc.2017.17.e11
PMID:28680723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5489547/
Abstract

Despite the decreasing incidence and mortality from gastric cancer, it remains a major health problem worldwide. Ninety percent of cases are adenocarcinomas. Here, we report a case of gastric adenocarcinoma developed after successful treatment of prior primary gastric diffuse large B-cell lymphoma (DLBCL). Our patient was an elderly man with primary gastric DLBCL in whom complete remission was achieved after R-CHOP (cyclophosphamide, adriamycin, vincristine, prednisolone plus rituximab) chemotherapy. infection persisted despite adequate treatment leading to sustained chronic gastritis. The mean time to diagnose metachronous gastric carcinoma was seven years. We believe that a combination of many risk factors, of which chronic infection the most important, led to the development of gastric carcinoma following primary gastric lymphoma. In summary, patients who have been successfully treated for primary gastric lymphoma should be followed up at regular short intervals. infection should be diagnosed promptly and treated aggressively.

摘要

尽管胃癌的发病率和死亡率在下降,但它仍然是全球主要的健康问题。90%的病例为腺癌。在此,我们报告一例先前原发性胃弥漫性大B细胞淋巴瘤(DLBCL)成功治疗后发生胃腺癌的病例。我们的患者是一名患有原发性胃DLBCL的老年男性,在接受R-CHOP(环磷酰胺、阿霉素、长春新碱、泼尼松龙加利妥昔单抗)化疗后实现了完全缓解。尽管进行了充分治疗,但感染持续存在,导致持续性慢性胃炎。异时性胃癌的平均诊断时间为7年。我们认为,多种危险因素共同作用,其中慢性感染最为重要,导致原发性胃淋巴瘤后发生胃癌。总之,原发性胃淋巴瘤成功治疗的患者应定期进行短期随访。应及时诊断感染并积极治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/5aed34a7e852/jgc-17-180-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/238d6f86dbfa/jgc-17-180-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/2bd689959da4/jgc-17-180-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/131650b1d89b/jgc-17-180-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/0798749b9d46/jgc-17-180-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/5aed34a7e852/jgc-17-180-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/238d6f86dbfa/jgc-17-180-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/2bd689959da4/jgc-17-180-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/131650b1d89b/jgc-17-180-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/0798749b9d46/jgc-17-180-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1b6/5489547/5aed34a7e852/jgc-17-180-g005.jpg

相似文献

1
Gastric Adenocarcinoma Secondary to Primary Gastric Diffuse Large B-cell Lymphoma.继发于原发性胃弥漫性大B细胞淋巴瘤的胃腺癌
J Gastric Cancer. 2017 Jun;17(2):180-185. doi: 10.5230/jgc.2017.17.e11. Epub 2017 Mar 22.
2
Increased risk of gastric adenocarcinoma after treatment of primary gastric diffuse large B-cell lymphoma.原发性胃弥漫性大B细胞淋巴瘤治疗后胃腺癌风险增加。
BMC Cancer. 2013 Oct 26;13:499. doi: 10.1186/1471-2407-13-499.
3
Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary?局部高级别胃B细胞淋巴瘤的化疗管理:需要多少剂量?
Ann Oncol. 2002 Jul;13(7):1094-8. doi: 10.1093/annonc/mdf178.
4
Progression of Primary Gastric Diffuse Large B-Cell Lymphoma after Eradication.根除治疗后原发性胃弥漫性大B细胞淋巴瘤的进展
Case Rep Gastroenterol. 2020 Oct 28;14(3):534-539. doi: 10.1159/000508849. eCollection 2020 Sep-Dec.
5
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma.利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松(R-CHOP方案)用于治疗早期胃弥漫性大B细胞淋巴瘤。
Ann Oncol. 2004 Jul;15(7):1086-90. doi: 10.1093/annonc/mdh261.
6
Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.单纯幽门螺杆菌(HP)感染而非 HP 引起的萎缩性胃炎会增加胃癌的风险:日本的一项病例对照研究。
Ann Hematol. 2019 Aug;98(8):1981-1987. doi: 10.1007/s00277-019-03721-y. Epub 2019 Jun 8.
7
[Clinical characteristics and treatment strategies for early-stage primary gastric diffuse large B-cell lymphoma].[早期原发性胃弥漫性大B细胞淋巴瘤的临床特征及治疗策略]
Zhonghua Yi Xue Za Zhi. 2018 Jun 26;98(24):1945-1950. doi: 10.3760/cma.j.issn.0376-2491.2018.24.011.
8
The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma.CHOP 方案与 R-CHOP 方案在原发性胃弥漫大 B 细胞淋巴瘤中的比较。
Ann Hematol. 2012 Nov;91(11):1731-9. doi: 10.1007/s00277-012-1512-4. Epub 2012 Jul 3.
9
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).与利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松龙相比,利妥昔单抗、环磷酰胺、非聚乙二醇化脂质体阿霉素、长春新碱和泼尼松龙在弥漫性大B细胞淋巴瘤患者一线治疗中的心脏毒性:奥地利癌症药物治疗工作组[Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14)的一项随机III期研究。
Eur J Cancer. 2016 May;58:112-21. doi: 10.1016/j.ejca.2016.02.004. Epub 2016 Mar 15.
10
Early cancer of the stomach arising after successful treatment of gastric MALT lymphoma in patients with autoimmune disease.自身免疫性疾病患者胃MALT淋巴瘤成功治疗后发生的早期胃癌。
Scand J Gastroenterol. 2003 Mar;38(3):294-7. doi: 10.1080/00365520310000582.

引用本文的文献

1
Diagnosis by Volatile Organic Compounds in Exhaled Breath in Exhaled Breath from Patients with Gastric and Colorectal Cancers.呼气中挥发性有机化合物诊断胃癌和结直肠癌患者的呼气。
Int J Mol Sci. 2022 Dec 21;24(1):129. doi: 10.3390/ijms24010129.
2
Malignant gastrointestinal neuroectodermal tumor, presenting as a second malignancy after gastric adenocarcinoma: a case report and literature review.恶性胃肠道神经外胚层肿瘤,作为胃腺癌后的第二原发恶性肿瘤:一例报告及文献复习
J Gastrointest Oncol. 2019 Dec;10(6):1144-1150. doi: 10.21037/jgo.2019.08.04.

本文引用的文献

1
Increased risk of gastric adenocarcinoma after treatment of primary gastric diffuse large B-cell lymphoma.原发性胃弥漫性大B细胞淋巴瘤治疗后胃腺癌风险增加。
BMC Cancer. 2013 Oct 26;13:499. doi: 10.1186/1471-2407-13-499.
2
Metachronous early gastric adenocarcinoma presenting coinstantaneously with complete remission of stage IV gastric MALT lymphoma.异时性早期胃腺癌与IV期胃黏膜相关淋巴组织淋巴瘤完全缓解同时出现。
Arab J Gastroenterol. 2013 Mar;14(1):20-3. doi: 10.1016/j.ajg.2013.01.004. Epub 2013 Mar 13.
3
Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: A review of the literature.
胃腺癌与胃淋巴瘤的同步和异时发生:文献综述
World J Gastroenterol. 2006 Jun 14;12(22):3564-74. doi: 10.3748/wjg.v12.i22.3564.
4
Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?异时性胃黏膜相关淋巴组织淋巴瘤和早期胃癌:残留淋巴瘤是否为胃癌发生的危险因素?
Ann Oncol. 2005 Aug;16(8):1232-6. doi: 10.1093/annonc/mdi242. Epub 2005 May 12.
5
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.预测胃肠化生进展的因素:一项关于幽门螺杆菌根除的随机试验结果
Gut. 2004 Sep;53(9):1244-9. doi: 10.1136/gut.2003.034629.
6
Primary gastric lymphoma.原发性胃淋巴瘤
World J Gastroenterol. 2004 Jan;10(1):5-11. doi: 10.3748/wjg.v10.i1.5.
7
The World Health Organization (WHO) classification of the myeloid neoplasms.世界卫生组织(WHO)对髓系肿瘤的分类。
Blood. 2002 Oct 1;100(7):2292-302. doi: 10.1182/blood-2002-04-1199.
8
Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.儿童癌症五年幸存者中的第二原发性恶性肿瘤:儿童癌症幸存者研究
J Natl Cancer Inst. 2001 Apr 18;93(8):618-29. doi: 10.1093/jnci/93.8.618.
9
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.幽门螺杆菌cagA+菌株感染与食管和贲门腺癌风险之间的负相关关系。
Cancer Res. 1998 Feb 15;58(4):588-90.
10
Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathological study of 12 patients.同步性和异时性原发性胃淋巴瘤与腺癌:12例患者的临床病理研究
Cancer. 1997 Mar 15;79(6):1077-85.